Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Rutledge Clement

Orthopaedic Surgery New Orleans, LA Medical Doctor

NPI 1639431802 CMS profile 2784687

200 Henry Clay Ave, New Orleans, LA 70118

Open in the dashboard

General payments

$11,669

85 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Rutledge Clement of New Orleans, LA is reported in the CMS Open Payments database as having received $11,669 across 85 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 72nd percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,435 13
2024 General $837 9
2023 General $2,267 37
2022 General $692 12
2021 General $2,824 10
2020 General $1,937 3
2019 General $1,678 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Rutledge Clement
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Rutledge Clement were reported at $1,435. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Rutledge Clement Orthopaedic Surgery median Middle half National median
2019 $1,678 $644 $140–$2,844 $163
2020 $1,937 $312 $75–$1,860 $114
2021 $2,824 $520 $117–$2,495 $132
2022 $692 $598 $128–$2,731 $149
2023 $2,267 $461 $128–$2,264 $160
2024 $837 $497 $134–$2,475 $164
2025 $1,435 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Alon Medical Technology $6,044 8 payments
  2. Medtronic, Inc. $2,097 30 payments
  3. Arthrex, Inc. $986 5 payments
  4. Stryker Corporation $861 9 payments
  5. Globus Medical, Inc. $695 14 payments
  6. OrthoPediatrics Corp. $371 3 payments
  7. Zimvie Inc. $199 3 payments
  8. Bioventus LLC $99 3 payments
  9. DePuy Synthes Sales Inc. $86 3 payments
  10. CONMED Corporation $71 2 payments
  11. Other $161 5 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Education $5,650 4 payments
  2. Food and Beverage $3,538 68 payments
  3. Travel and Lodging $2,481 13 payments
Products named General payments · program years 2019–2025
  1. MAZOR X SYSTEM $1,379 15 payments
  2. UNID_PASS $289 9 payments
  3. MESA SPINAL SYSTEM $267 2 payments
  4. Rod Link Reducer $252 3 payments
  5. O-ARM $251 4 payments
  6. VARIAX $245 3 payments
  7. Marvel Growing Rod $202 2 payments
  8. The Tether $199 3 payments
  9. Xvision $184 5 payments
  10. MAGEC Spinal Bracing and Distraction System $167 1 payment
  11. Other $1,794 39 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

85 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record